Arterys Cardio DL

by Arterys (now part of Tempus)  · Based in United States → — The medical imaging AI platform allowing you to weave leading AI clinical applications directly into your existing PACS or EHR driven workflow to make it a natural extension of what you already do.
Cardiology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Regulatory Status Disclosed

Overview

Arterys Cardio DL is an innovative, FDA-cleared AI tool designed for cardiac MRI analysis. Leveraging cloud computing and deep learning, it automates and streamlines the interpretation of cardiac magnetic resonance (CMR) images, significantly reducing the time required for analysis from traditional manual methods. The platform provides automated, editable ventricle segmentations that are as accurate as those performed manually by experienced physicians. It integrates seamlessly into existing PACS or EHR workflows, enhancing diagnostic decision-making, improving efficiency, and ultimately aiming for better patient outcomes. Arterys Cardio DL is vendor-agnostic and supports comprehensive cardiac MRI post-processing, including 4D Flow visualization and quantification, quantitative delayed enhancement, and semi-quantitative perfusion analysis.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated ventricle segmentations for cardiac MRI
  • Deep learning algorithms for image analysis
  • Cloud-based platform for accessibility and performance
  • Vendor-agnostic compatibility
  • Rapid analysis (seconds vs. 30-60 minutes)
  • Editable automated contours
  • 4D Flow post-processing for blood flow visualization and quantification
  • Quantitative Delayed Enhancement analysis
  • Semi-Quantitative Perfusion analysis
  • Integration with PACS/EHR workflows

Use Cases

  • Cardiac MRI image interpretation and analysis
  • Assessment of ventricular function and volumes
  • Visualization and quantification of blood flow within and around the heart
  • Reducing radiologist workload and improving efficiency
  • Enhancing diagnostic accuracy and consistency in cardiac imaging
  • Facilitating data-driven medicine and clinical research

What Physicians Need to Know

Cardiac CT/MRI Analysis
Arterys Cardio DL leverages deep learning and cloud computing to automate the analysis of cardiac MRI images, providing automated, editable ventricle segmentations that are as accurate as those performed manually by experienced physicians. It can process scans in seconds, a task that typically takes human analysts 30 minutes to an hour. The platform also offers deep learning-based semi-quantitative perfusion and quantitative delayed enhancement analysis, including scar quantification and extent enhancement on a 17-segment AHA plot. Additionally, it supports T1 and ECV quantification, T2 quantification, atrial volume measurements, and wall thickness measurements. The Arterys Viewer offers multimodal support, including for MRI, CT, X-ray, and ultrasound images.
Heart Failure Risk Prediction
Arterys Cardio DL aims to help clinicians detect, predict, and track heart problems. AI models, including deep learning, are being developed to predict heart failure risk by analyzing various patient data, including cardiac imaging. Cardiovascular MRI combined with AI can predict heart failure risk by estimating pressure in the heart.
Coronary Artery Assessment
AI and machine learning are transforming the non-invasive assessment of coronary vessels, improving diagnostic accuracy and providing predictive insights. Deep learning in cardiology is promising for analyzing coronary angiography to predict stenosis, offering a non-invasive alternative.
AHA/ACC Guideline Alignment
Arterys Cardio DL supports quantitative delayed enhancement and semi-quantitative perfusion analysis, with users able to obtain scar quantification and extent enhancement on a 17-segment AHA plot.
Physician Tip

Arterys Cardio DL significantly reduces the time required for cardiac MRI analysis, automating tedious manual tasks and providing accurate, consistent measurements in seconds. This allows for faster processing of complex cardiac MR examinations, enabling quicker diagnostic decisions and improved workflow efficiency. The platform's ability to provide quantitative data, such as scar quantification and ventricular volumes, can aid in the prognosis and management of various cardiac conditions. The cloud-based nature of the platform allows for accessibility and collaboration.

The Arterys platform is designed to integrate with existing electronic health records (EHRs), picture archiving and communication systems (PACS), and radiology information systems (RIS) environments, as well as dictation solutions. It is a vendor-agnostic solution. The platform is cloud-based, allowing for accessibility from validated devices without the exchange of Protected Health Information (PHI) directly with Arterys. Arterys has joined Tempus, and its product will be integrated into Tempus' solutions to provide a comprehensive patient view.

Details

Category Cardiology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27]
Mobile AppYes (web-based viewer accessible on tablet and phone)
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Radiology

What the Web Says

Arterys Cardio DL is a cloud-based, AI-powered medical imaging software designed to automate and expedite the analysis of cardiac MRI images. It received FDA 510(k) clearance in January 2017, making it the first FDA-approved medical imaging analytics cloud software with deep learning capabilities. The software aims to assist physicians in interpreting medical images by providing automated, editable ventricle segmentations, which are as accurate as those performed manually by experienced physicians. This significantly reduces the time required for analysis, from up to an hour to mere seconds or minutes.

Overall: Positive

Strengths

  • Automates tedious manual tasks in cardiac MRI analysis, saving significant time for radiologists.
  • Provides automated, editable ventricle segmentations that are as accurate as those performed manually by experienced physicians.
  • Leverages cloud computing, allowing for rapid performance, easy deployment, and accessibility from any validated device.
  • Enhances clinician workflow, streamlining and speeding analysis of cardiac MR images.
  • Vendor-agnostic and developed using data from several thousand cardiac cases.
  • Collects ground-truth data to continuously optimize its deep learning model as new data is collected from users.

Limitations

  • Some users note a learning curve for advanced features.
  • Concerns about data and privacy, though Arterys states PHI is erased and not accessed by the platform.
  • Perfusion and Delayed Enhancement features were for research use only in the U.S. at one point due to contrast agents used.

Based on reviews from: reddit.com, mayoclinic.org, acs.org, nih.gov, usmle.org, expertini.com, capterra.com, dochub.com, auntminnie.com, dicardiology.com, slashdot.org, Current time information in San Francisco, CA, US., medicpro.london, itnonline.com, medtechinnovator.org, radiologybusiness.com, g2.com, biospace.com, forbes.com, fiercebiotech.com, glorikian.com, medicaldevice-network.com, cardiovascularbusiness.com

Last updated: 2026-10-29

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Arterys Cardio DL

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

itnonline.com
Arterys Cardio DL Cloud MRI Analytics Software Receives FDA Clearance
Arterys received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Cardio DL application, making it the first FDA-cleared technology to use cloud computing and deep learning in a clinical setting for cardiac MRI analysis. The software provides automated, editable ventricle segmentations that are as accurate as those performed manually by experienced physicians.
2017-01
medicaldevice-network.com
Arterys obtains FDA 510(k) clearance for Cardio DL application
Arterys, a software-as-a-service (SAAS) analytics platform developer, secured FDA 510(k) clearance for its Cardio DL application to support cardiac MRI, utilizing cloud computing and deep learning algorithms. This approval signifies a major regulatory milestone, demonstrating the power of deep learning and cloud supercomputation to assist physicians in interpreting medical images and automating tedious manual tasks.
2017-01
dicardiology.com
Arterys Cardio DL Cloud MRI Analytics Software Receives FDA Clearance
Arterys Cardio DL, the first FDA-cleared technology to leverage cloud computing and deep learning in a clinical setting, provides automated, editable ventricle segmentations based on conventional cardiac MRI exams. This U.S. clearance complements the CE Mark received in late December for commercialization in Europe.
2017-01
fiercebiotech.com
Arterys gets FDA nod for deep learning-powered cardiac imaging software
Arterys received FDA clearance for its Cardio DL software, which uses deep learning to provide automated ventricle segmentations from cardiac MRI scans with accuracy comparable to manual segmentations by physicians. The software processes scans in 10 seconds, significantly faster than traditional methods, and is designed to accelerate data-driven medicine while protecting patient privacy.
2017-01
cardiovascularnews.com
Arterys Cardio DL gets FDA, CE Mark for cardiac MRI analysis
Arterys Cardio DL has received 510(k) clearance from the FDA and a CE mark for its deep learning application, which provides automated and editable ventricle segmentations from cardiac MRI images. The software leverages cloud computing and deep learning to aid physicians in interpreting medical images, eliminating tedious manual tasks and providing precise ventricular function in seconds.
2017-01
cardiovascularbusiness.com
Arterys Cardio DL Cloud MRI Analytics Software Receives FDA Clearance
The FDA has granted Arterys clearance to market its Cardio DL application, marking the first time the agency has approved a technology leveraging cloud computing and deep learning in a clinical setting. This software provides automated, editable ventricle segmentations based on conventional cardiac MRI images, as accurate as those performed manually by experienced physicians.
2017-01
auntminnie.com
Arterys Cardio DL gets FDA clearance
Imaging software developer Arterys has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Arterys Cardio DL application, which utilizes cloud computing and deep learning. Cardio DL provides automated, editable ventricle segmentations based on cardiac MR images and was developed using data from several thousand cardiac cases.
2017-01
medicpro.london
Arterys Cardio DL: Revolutionizing Cardiac MRI with AI
Arterys Cardio DL, an FDA-approved software, significantly reduces cardiac MRI result wait times for patients by using deep learning algorithms to assess and analyze heart scans, automating ventricle segmentations. The platform, which received FDA clearance on January 9, 2017, is noted for its ability to interpret CMR images in minutes, a task that traditionally took radiologists up to 30 minutes.
2024-07

Videos

Product demos, reviews, and walkthroughs for Arterys Cardio DL.

Loading videos...

View all on YouTube

Frequently Asked Questions

Arterys Cardio DL is an FDA-cleared, cloud-based AI software that automates the segmentation of cardiac MRI images, providing precise and consistent ventricular function measurements in seconds. This significantly reduces the time radiologists spend on manual tasks, allowing for faster analysis and potentially improving workflow efficiency in cardiology departments.
Arterys Cardio DL received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2017, making it the first FDA-cleared technology to leverage cloud computing and deep learning in a clinical setting. It also received CE Mark approval in Europe. The platform is designed to be HIPAA and EU GDPR compliant, and integrates with existing PACS and EHR systems.
Arterys Cardio DL is designed with patient data privacy in mind. Personal health information (PHI) is stripped from imaging data at the point of collection, and Arterys itself never receives any information that can identify individuals. When accredited users log in, the system retrieves imaging data and analytical results from Arterys' cloud and PHI from the hospital's secure server, rebuilding it for the user.
While Arterys Cardio DL automates image analysis and provides quantitative data, it does not make diagnoses or treatment plans; radiologists still interpret the scans. The software's accuracy is comparable to experienced clinical annotators, but it's a tool to aid physicians, not replace them.
Arterys MICA, which includes Cardio DL, generally has license pricing in the higher range compared to competitors like Philips IntelliSpace Portal, GE Healthcare Centricity, Siemens Healthineers syngo.via, and Mim Software, especially considering its AI-powered features. While a small business might start around $500 per user/month, an enterprise with 100 users could exceed $20,000 monthly, with additional costs for implementation, customization, training, and exceeding storage limits.

Compare Arterys Cardio DL

VS
Arterys Cardio DL vs EchoNext
Cardiology AI Adjacent · 65/100
Both Arterys Cardio DL and EchoNext are FDA-cleared AI tools in cardiology, but they focus on different diagnostic modalities. Arterys Cardio DL specializes in automating ventricle segmentations for…
VS
Arterys Cardio DL vs PMcardio
Cardiology AI Adjacent · 60/100
Arterys Cardio DL focuses on advanced cardiac MRI analysis, providing automated ventricle segmentations and 4D Flow post-processing for detailed anatomical and functional insights. In contrast, PMcardio specializes in…
VS
Arterys Cardio DL vs KardiaPro
Cardiology AI Adjacent · 65/100
Arterys Cardio DL focuses on AI-powered analysis of cardiac MRI for detailed ventricle segmentations and blood flow visualization, ideal for in-depth diagnostic imaging. In contrast, KardiaPro is designed…
VS
Arterys Cardio DL vs KardiaPro
Cardiology AI Adjacent · 60/100
Arterys Cardio DL is designed for advanced cardiac MRI analysis, focusing on automated ventricle segmentations and 4D Flow post-processing for detailed diagnostic imaging. In contrast, KardiaPro is a…

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-17 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.